US: Ranbaxy pay-for-delay trial starts

US: Ranbaxy pay-for-delay trial starts

As complex as reverse-payment antitrust lawsuits can be, the one being litigated against generic drug maker Ranbaxy over its settlement with Cephalon can be broken down to the difference between fine and coarse salt, said one of the attorneys bringing the case. Foley & Lardner attorney James Matthews, who is representing fellow generic drug maker […]

The Rising Tide: Competition Law Enforcement in the Indian Pharmaceutical Sector

This article is part of a Chronicle. See more from this Chronicle Kalyani Singh, Nov 24, 2014 Given the sensitivity and direct impact on consumers, it is of little surprise that the pharmaceutical industry—if not an absolute—ranks as one of the most controversial and actively pursued sectors by antitrust authorities across the world. India is […]